These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24020673)

  • 1. In-stent restenosis of drug-eluting stents.
    Minha S; Pichard AD; Waksman R
    Future Cardiol; 2013 Sep; 9(5):721-31. PubMed ID: 24020673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.
    De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
    Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis?
    Alfonso F
    J Am Coll Cardiol; 2010 Jun; 55(24):2717-20. PubMed ID: 20538164
    [No Abstract]   [Full Text] [Related]  

  • 5. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-stent restenosis in the drug-eluting stent era.
    Dangas GD; Claessen BE; Caixeta A; Sanidas EA; Mintz GS; Mehran R
    J Am Coll Cardiol; 2010 Nov; 56(23):1897-907. PubMed ID: 21109112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare and late angiographic presentation of DES fracture.
    Alizadehranjbar K; Cheung PK; Hui W
    J Invasive Cardiol; 2008 Dec; 20(12):E324-6. PubMed ID: 19057037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late restenosis following placement of a sirolimus eluting stent for in-stent restenosis.
    Ali OA; Lowe H; Kritharides L; Brieger D
    Heart Lung Circ; 2007 Feb; 16(1):50-1. PubMed ID: 17196881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
    Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
    JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registry data evaluating the effectiveness of drug-eluting stents for the treatment of symptomatic in-stent restenosis.
    Worthley MI; Anderson TJ; Traboulsi M; Charbonneau F; Curtis MJ; Hansen JL; Knudtson ML; Spence FP; Goodhart DM
    Heart Lung Circ; 2006 Oct; 15(5):300-5. PubMed ID: 16877042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice.
    Appleby CE; Khattar RS; Morgan K; Clarke B; Curzen N; Neyses L; Fath-Ordoubadi F
    EuroIntervention; 2011 Jan; 6(6):748-53. PubMed ID: 21205600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restenosis treatment in the drug-eluting stent era.
    Presbitero P; Boccuzzi G
    Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of drug-eluting stents for treating in-stent restenosis of drug-eluting stents (from the Korean DES ISR multicenter registry study [KISS]).
    Ko YG; Kim JS; Kim BK; Choi D; Hong MK; Jeon DW; Yang JY; Ahn YK; Jeong MH; Yu CW; Yun KH; Lim DS; Jang Y;
    Am J Cardiol; 2012 Mar; 109(5):607-13. PubMed ID: 22172241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents.
    Kandzari DE; Leon MB; Meredith I; Fajadet J; Wijns W; Mauri L
    JACC Cardiovasc Interv; 2013 May; 6(5):504-12. PubMed ID: 23602459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of drug-eluting stent restenosis: an emerging challenge.
    Aminian A; Kabir T; Eeckhout E
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):108-16. PubMed ID: 19199365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.